Clinical Trials in Phoenix

Showing 14261-14280 of 16,646 trials

Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects

NCT00828204

The primary objective of the study was to evaluate the safe and effective use of the single-use autoinjector for the intramuscular (IM) delivery of liquid Avonex® (interferon beta-1a) in participants with multiple sclerosis (MS).

Multiple Sclerosis

Biogen95 participantsStarted Jan 2009

Gilbert, Arizona, United States • Phoenix, Arizona, United States • Maitland, Florida, United States +13 more locations

WITHDRAWNPhase 3< 1 mile

An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men

NCT02082197

This is an open-study with a 26 week open label treatment period followed by an optional 26 week open label extension. The total treatment period will be 52 weeks.

HypogonadismTestosterone Deficiency

AbbVieStarted Mar 2014

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Mesa, Arizona, United States +39 more locations

Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects

An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men

Find Trials by Condition in Phoenix

Fatty Acid Binding Protein 2 (FABP2) Ancillary Proposal

Markers and Mechanisms of Vascular Disease in Type II Diabetes

Global® AP™ Total Shoulder Arthroplasty

Dose-Escalation Safety and Pharmacokinetic Study of ATX-101

PHA-739358 for the Treatment of Multiple Myeloma

Study of Low Level Laser Therapy to Treat Chronic Heel Pain Arising From Plantar Fasciitis

Growth and Tolerance of Infants Fed Infant Formulas

A Study to Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) Versus Placebo in Cancer Patients Who Develop Chemotherapy-induced Peripheral Neuropathy

Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer

VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection

A Trial of Degarelix in Patients With Prostate Cancer

Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy

Computed Tomography Dose Reduction Using Sequential or Fast Pitch Sprial Technique

An Evaluation of PDI-320 in Comparison to Its Monads in Adults With Rosacea

Sofosbuvir With Pegylated Interferon and Ribavirin Hepatitis C Virus (HCV) Genotypes 1,4,5,6

Trial Evaluating the Safety and Effectiveness of NUBAC™ Disc Arthroplasty

Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis

An Efficacy and Safety Study of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia